Stock is now lower than it was in late January 2018 despite all good news since then. I am very long but I believe shareholders need to start putting pressure on this management team for some answers.
Where is Sanyal's presentation? He presented on Sunday. Two trading days have now gone by in Australia with no update. Why was there no update regarding the colitis presentation last month in Europe? What is going on with Amazon taking over direct sales of Travelan? Why does the company trade at a U.S. $27M market cap despite a Phase 3 ready liver disease drug and such great prospects with fully paid for Phase 2 NIH trials in ASH and PNAFLD? The DoD work on Travelan too .... just unreal.
Horrific Price Action
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
